Human Health Holdings Limited

Human Health Holdings Limited

1419.HK
Human Health Holdings LimitedHK flagHong Kong Stock Exchange
0.75
HKD
-0.01
- -
284.66MMarket Cap
Human Health Holdings Limited
1419.HK
(Hong Kong Stock Exchange)

Recent

price

0.75

P/E

ratio

- -

div

yld

- -

ROIC.AI

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
1.32
1.44
1.7
1.69
1.33
1.43
1.42
1.2
1.72
2.96
2.64
1.56
1.7
Revenue per Share
0.13
0.15
0.13
0.08
0.04
0.07
0.07
-0.11
0.38
0.99
0.48
0.06
0.07
Basic EPS, GAAP
0.13
0.13
0.2
0.06
0.03
0.11
0.11
0.07
0.19
0.58
1.53
-0.07
0.24
Free Cash Flow per Basic Share
0.07
0.14
0.02
0.17
0.03
0.02
0.03
0.03
- -
0.12
0.3
0.16
0.03
Dividend per Share
0.31
0.32
0.16
0.22
0.19
0.24
0.27
0.01
0.01
1.38
1.56
1.46
1.51
Book Value per Share
0.37
0.39
0.14
0.57
0.58
0.64
0.73
0.58
0.98
1.86
2.04
1.93
1.85
Tangible Book Value per Share
253
253
253
295
362
362
372
380
380
380
380
380
380
Basic Weighted Avg Shares
334
365
430
499
481
518
529
454
655
1,122
1,002
591
644
Sales/Revenue/Turnover
12.33
13.36
12.22
10.52
5.01
7.39
6.79
-3.35
24.84
37.48
24.64
1.06
3.73
Operating Margin (%)
6
6
7
9
9
10
12
75
68
63
75
68
68
Depreciation Expense
34
39
34
23
13
24
27
-40
144
375
181
24
26
Net Income, GAAP
16.05
17.43
20.94
34.55
37.35
27.12
24.12
- -
14.43
15.71
24.28
8.94
11.05
Effective Tax Rate (%)
10.21
10.61
7.85
4.7
2.8
4.65
5.04
-8.9
22.06
33.46
18.05
4.09
4.09
Profit Margin (%)
73
76
18
126
169
180
128
62
231
431
448
398
384
Working Capital
- -
- -
- -
- -
- -
- -
- -
34
14
107
98
66
69
LT Debt
94
98
85
215
257
274
314
259
410
742
808
767
782
Total Equity
- -
39.27
35.85
17.44
5.71
10.3
8.91
- -
32.15
46.88
17.86
0.58
2.35
Return on Invested Capital (%)
- -
41.62
38.4
26.26
16.52
32.23
27.56
- -
166.21
96.52
25.17
4.29
4.53
Return on Capital (%)
- -
48.85
55.23
43.92
20.15
31.47
28.62
-77.05
3,805.4
142.36
32.41
4.21
4.67
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
32.18%
29%
1.97%
Free Cash Flow
15.56%
-0.77%
-445.33%
Net Income, GAAP
-66.28%
-85.51%
8.88%
Sales/Revenue/Turnover
8.11%
14.6%
9.07%
Total Cash Common Dividend
- -
1,645.83%
-82.5%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
591
2025
- -
- -
- -
- -
644
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.06
2025
- -
- -
- -
- -
0.07
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.16
2025
- -
- -
- -
- -
0.03
2026
- -
- -
- -
- -
- -
Business
Human Health Holdings Limited operates as a comprehensive healthcare service provider primarily in Hong Kong. The company offers a broad range of medical services including general practice services such as general consultation, diagnostics, preventative health, minor procedures, vaccinations, and physical check-ups. It provides specialty medical services across various disciplines including general surgery, orthopedics and traumatology, ophthalmology, otorhinolaryngology, pediatrics, obstetrics and gynecology, gastroenterology and hepatology, cardiology, pediatric surgery, dermatology and venereology, psychiatry, radiology, urology, nephrology, neurosurgery, anesthesiology, and oncology. In addition, Human Health offers extensive dental care services covering general dentistry, dental implants, root canal therapy, microscopic endodontics, crown and bridge, oral surgery, orthodontic treatment, 3D guided implant and surgery, intraoral digital impressions, CAD/CAM dentistry, laser dentistry, cone-beam computed tomography, and cosmetic and specialist dentistry. The company also provides physiotherapy, medical aesthetics, nutritionist services, health and wellness programs, endoscopy, and advanced medical diagnostics. Founded in 1996, Human Health Holdings is headquartered in Hong Kong and is engaged in serving individuals and corporate clients with a full spectrum of prevention, healthcare, diagnosis, and treatment services. Recent major developments include a strategic network expansion with openings of new medical centers in key districts of Hong Kong, which has driven revenue growth. The company has significantly increased its digital investments by upgrading its IT infrastructure to accelerate digital transformation and launched a proprietary integrated clinical platform across its general and specialty medical centers to enhance patient care and operational efficiency. Additionally, it introduced an omnichannel messaging platform, including WhatsApp inquiry functions, to improve public inquiry response times and customer engagement. Human Health maintains strong collaborations with the Hong Kong Government on public health initiatives such as seasonal influenza vaccination subsidies, chronic disease co-care, colorectal cancer screening, and rehabilitation programs for injured workers. These efforts aim to expand healthcare accessibility and service quality. The company also reported improved financial performance with increased revenue and net profit on a recent fiscal basis, indicating operational improvements through cost management and process optimization. Human Health Holdings operates through a network of medical and dental centers in Hong Kong, servicing a diverse customer base including individual patients and corporate groups. The company emphasizes a people-oriented corporate culture and leverages its comprehensive infrastructure and management expertise to continuously expand and enhance its healthcare offerings. This description reflects the latest available public information through 2025 on Human Health Holdings Limited and its ongoing strategic and operational developments.